Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 7, 2011 - Issue 4
Submit an article Journal homepage
445
Views
2
CrossRef citations to date
0
Altmetric
Special Focus Issue: Systemic sclerosis - Foreword

Novel insights in the pathogenesis of systemic sclerosis

Timothy RDJ Radstake Department of Rheumatology, Radboud University Nijmegen Medical Centre, Geert Grooteplein 8, 6500 HB Nijmegen, The Netherlands and Scleroderma Center, Boston University School of Medicine, 715 Albany Street, Boston, MA, USA. [email protected]
Pages 389-390 | Published online: 10 Jan 2014

References

  • Michels-van Amelsfort JMR, Walter GJ, Taams LS. CD4+CD25+ regulatory T cells in systemic sclerosis and other rheumatic diseases. Expert Rev. Clin. Immunol.7(4), 499–514 (2011).
  • Usategui A, del Rey MJ, Pablos JL. Fibroblast abnormalities in the pathogenesis of systemic sclerosis. Expert Rev. Clin. Immunol.7(4), 491–498 (2011).
  • York MR. Novel insights on the role of the innate immune system in systemic sclerosis. Expert Rev. Clin. Immunol.7(4), 481–489 (2011).
  • Sargent JL, Whitfield ML. Capturing the heterogeneity in systemic sclerosis with genome-wide expression profiling. Expert Rev. Clin. Immunol.7(4), 463–473 (2011).
  • Jüngel A, Distler JHW, Gay S, Distler O. Epigenetic modifications: novel therapeutic strategies for systemic sclerosis? Expert Rev. Clin. Immunol.7(4), 475–480 (2011).
  • Broen JCA, Coenen MJH, Radstake TRDJ. Deciphering the genetic background of systemic sclerosis. Expert Rev. Clin. Immunol.7(4), 449–462 (2011).
  • Beretta L, Santaniello A. Models for prediction of death in systemic sclerosis: current perspectives and future directions. Expert Rev. Clin. Immunol.7(4), 391–393 (2011).
  • Cutolo M, Sulli A, Smith V. Evaluating microangiopathy in systemic sclerosis: what have we learnt and what is left to discover? Expert Rev. Clin. Immunol.7(4), 395–397 (2011).
  • Derk CT. Disease-modifying drugs for systemic sclerosis: why have we not found them yet? Expert Rev. Clin. Immunol.7(4), 399–401 (2011).
  • Barnes J, Agrawal SK. Targeting STAT4 in systemic sclerosis: a promising new direction. Expert Rev. Clin. Immunol.7(4), 445–448 (2011).
  • Steen VD. The pleomorphism of systemic sclerosis: are we ready for ‘personalized medicine’ in scleroderma? Expert Rev. Clin. Immunol.7(4), 403–405 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.